A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

We present a generic dendritic cell (DC) vaccine strategy for patients with renal cell carcinoma (RCC) based on the use of RNA as a source of multiplex tumor-associated antigens (TAAs). Instead of preparing RNA from tumor tissue of each individual RCC patient, we propose to substitute RNA prepared f...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, Christiane, Regn, Sybille, Weinzierl, Andreas, Noessner, Elfriede, Schendel, Dolores J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188079/
https://www.ncbi.nlm.nih.gov/pubmed/16045799
http://dx.doi.org/10.1186/1479-5876-3-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188079/
https://www.ncbi.nlm.nih.gov/pubmed/16045799
http://dx.doi.org/10.1186/1479-5876-3-29

Ejemplares similares